Mostrar el registro sencillo del ítem
Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1
| dc.creator | Obiedat A., Seidel E., Mahameed M., Bernani O., Tsukerman P., Voutetakis K., Chatziioannou A., Mcmahon M., Avril T., Chevet E., Mandelboim O., Tirosh B. | en |
| dc.date.accessioned | 2023-01-31T09:40:59Z | |
| dc.date.available | 2023-01-31T09:40:59Z | |
| dc.date.issued | 2019 | |
| dc.identifier | 10.1096/fj.201801350RR | |
| dc.identifier.issn | 08926638 | |
| dc.identifier.uri | http://hdl.handle.net/11615/77370 | |
| dc.description.abstract | The unfolded protein response (UPR) is an adaptive signaling pathway activated in response to endoplasmic reticulum (ER) stress. The effectors of the UPR are potent transcription activators; however, some genes are suppressed by ER stress at the mRNA level. The mechanisms underlying UPR-mediated gene suppression are less known. Exploration of the effect of UPR on NK cells ligand expression found that the transcription of NK group 2 member D (NKG2D) ligand major histocompatibility complex class I polypeptide-related sequence A/B (MICA/B) is suppressed by the inositol-requiring enzyme 1 (IRE1)/X-box binding protein 1 (XBP1) pathway of the UPR. Deletion of IRE1 or XBP1 was sufficient to promote mRNA and surface levels of MICA. Accordingly, NKG2D played a greater role in the killing of IRE1/XBP1 knockout target cells. Analysis of effectors downstream to XBP1s identified E2F transcription factor 1 (E2F1) as linking UPR and MICA transcription. The inverse correlation between XBP1 and E2F1 or MICA expression was corroborated in RNA-Seq analysis of 470 primary melanoma tumors. While mechanisms that connect XBP1 to E2F1 are not fully understood, we implicate a few microRNA molecules that are modulated by ER stress and possess dual suppression of E2F1 and MICA. Because of the importance of E2F1 and MICA in cancer progression and recognition, these observations could be exploited for cancer therapy by manipulating the UPR in tumor cells.—Obiedat, A., Seidel, E., Mahameed, M., Berhani, O., Tsukerman, P., Voutetakis, K., Chatziioannou, A., McMahon, M., Avril, T., Chevet, E., Mandelboim, O., Tirosh, B. Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1. FASEB J. 33, 3481–3495 (2019). www.fasebj.org. © FASEB | en |
| dc.language.iso | en | en |
| dc.source | FASEB Journal | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064003217&doi=10.1096%2ffj.201801350RR&partnerID=40&md5=be7589e9a3ba19e06dcded9dd2a5c99c | |
| dc.subject | adenosine triphosphatase (calcium) | en |
| dc.subject | CRISPR associated protein | en |
| dc.subject | glycosylated protein | en |
| dc.subject | lysosome associated membrane protein 1 | en |
| dc.subject | major histocompatibility antigen class 1 | en |
| dc.subject | major histocompatibility complex class I polypeptide related sequence A | en |
| dc.subject | major histocompatibility complex class I polypeptide related sequence B | en |
| dc.subject | messenger RNA | en |
| dc.subject | natural killer cell receptor NKG2D | en |
| dc.subject | protein IRE1 | en |
| dc.subject | transcription factor E2F1 | en |
| dc.subject | unclassified drug | en |
| dc.subject | X box binding protein 1 | en |
| dc.subject | E2F1 protein, human | en |
| dc.subject | ERN1 protein, human | en |
| dc.subject | HLA antigen class 1 | en |
| dc.subject | KLRK1 protein, human | en |
| dc.subject | ligand | en |
| dc.subject | messenger RNA | en |
| dc.subject | MHC class I-related chain A | en |
| dc.subject | natural killer cell lectin like receptor subfamily K | en |
| dc.subject | protein serine threonine kinase | en |
| dc.subject | ribonuclease | en |
| dc.subject | transcription factor | en |
| dc.subject | transcription factor E2F1 | en |
| dc.subject | X box binding protein 1 | en |
| dc.subject | XBP1 protein, human | en |
| dc.subject | Article | en |
| dc.subject | cancer growth | en |
| dc.subject | cancer therapy | en |
| dc.subject | cytotoxicity | en |
| dc.subject | endoplasmic reticulum stress | en |
| dc.subject | gene deletion | en |
| dc.subject | gene knockout | en |
| dc.subject | human | en |
| dc.subject | human cell | en |
| dc.subject | melanoma | en |
| dc.subject | priority journal | en |
| dc.subject | protein analysis | en |
| dc.subject | protein expression | en |
| dc.subject | protein targeting | en |
| dc.subject | regulatory mechanism | en |
| dc.subject | RNA sequencing | en |
| dc.subject | signal transduction | en |
| dc.subject | transcription regulation | en |
| dc.subject | unfolded protein response | en |
| dc.subject | endoplasmic reticulum | en |
| dc.subject | genetic transcription | en |
| dc.subject | genetics | en |
| dc.subject | tumor cell line | en |
| dc.subject | unfolded protein response | en |
| dc.subject | Cell Line, Tumor | en |
| dc.subject | E2F1 Transcription Factor | en |
| dc.subject | Endoplasmic Reticulum | en |
| dc.subject | Endoplasmic Reticulum Stress | en |
| dc.subject | Endoribonucleases | en |
| dc.subject | Histocompatibility Antigens Class I | en |
| dc.subject | Humans | en |
| dc.subject | Ligands | en |
| dc.subject | NK Cell Lectin-Like Receptor Subfamily K | en |
| dc.subject | Protein-Serine-Threonine Kinases | en |
| dc.subject | RNA, Messenger | en |
| dc.subject | Signal Transduction | en |
| dc.subject | Transcription Factors | en |
| dc.subject | Transcription, Genetic | en |
| dc.subject | Unfolded Protein Response | en |
| dc.subject | X-Box Binding Protein 1 | en |
| dc.subject | John Wiley and Sons Inc. | en |
| dc.title | Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1 | en |
| dc.type | journalArticle | en |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||